📝 II: What is the evidence for chemo in #retroperitoneal #sarcoma

23 📚 -There is no evidence that addition of chemo to surgery improves RFS or OS in resectable #RPS

⭐️ STRASS2 to answer

Plz check out 🇦🇺 Australia and New Zealand Sarcoma Association national guidelines group review🙏

cancertreatmentreviews.com/article/S0305-…

📰: What is the association of pre-op biopsy w recurrence & survival in #RPS ?

🙌🏻 no assoc found of increased local recurrence or adverse survival outcomes.

Plz check out our review by Australia and New Zealand Sarcoma Association national #sarcoma guidelines group 🙏

David Gyorki Dario Callegaro Alessandro Gronchi
Chris O’Brien Lifehouse

.⁦ESMO - Eur. Oncology⁩ is launching a monthly virtual journal club. 3 papers discussed during 1h by the best experts. The goal is to update all colleagues about the latest advances wherever they are in the 🌍. First session on May ! Stay connected ! esmo.org/about-esmo-mee…

Our most complex biologic system—immunity—is reviewed in 3 new Cell papers, open-access
Adaptive
cell.com/cell/fulltext/…
Innate
cell.com/cell/fulltext/…
New insights
cell.com/cell/fulltext/… Ruslan Medzhitov

🔥What a nice birthday present to see our new bioRxiv up:
Glutaredoxin 3 (GLRX3) confers a fusion oncogene-dependent vulnerability to #Ewing #sarcoma

👇👇👇
tinyurl.com/r49pjsvw

Hopp-Kindertumorzentrum Heidelberg (KiTZ) DKFZ NCT Heidelberg VomLaborInDiePraxis Uni Heidelberg

See our latest review by Sara Arfan discussing Molecular #Heterogeneity in #Leiomyosarcoma and its implications for personalised medicine.

Read more about it👇
link.springer.com/article/10.100…

Looking forward to this at #ASCO24 from Erasca Memorial Sloan Kettering Cancer Center Mass General Cancer Center: Preliminary results from FLAGSHP-1: A phase 1 study of ERAS-601 as a monotherapy or in combination with cetuximab in patients (pts) previously treated for advanced chordoma. meetings.asco.org/abstracts-pres…

This new MD Anderson Cancer Center study aims to assess the safety and efficacy of image-guided ablation for soft tissue sarcoma metastases to the liver.

acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

OncoAlert

April is #EHEawareness month. Please like and share these facts!

📌 EHE is characterized by two gene fusions: WWTR1-CAMTA1 and YAP1-TFE3.
Approximately 90% of EHE cases are marked by fusion of the WWTR1 and CAMTA1 genes, with10% marked by fusion of the YAP1 and TFE3 genes.

We are inviting women sarcoma survivors in Australia to complete an anonymous online survey to help us better understand long-term side effects from cancer by sharing your experiences with us.
Please click on the link below to find out more: go.unimelb.edu.au/h98s

Looking forward to next #sarcoma journal club on 22/5 led by the Peter Mac team. Peter Mac Cancer Centre Australia and New Zealand Sarcoma Association

ESMO is launching a new journal on research in rare cancers, gold open access, online only.
Applications for the Editor-in-Chief position are now open.
📅Deadline: 20 May 2024

👉ow.ly/seqk50RlezC

Prospective TOP-GEAR study providing support for clinical utility of CGP+MTB in #rare cancers & #sarcoma

Of n=657 over >30 tumour types & 507 profiled
🔸25% were #STS
🎗️= 38% of the rare cancers (126/335)

14% #STS received genomically matched therapies🙌🏻

V. Interesting work👏

What happens in Zurich….goes to #ESMO25 ! Fantastic meeting and discussions for the educations, together with my scientific co-chair Toni Choueiri, MD ! New tracks, new concepts and the best experts! Mark your agendas for #Berlin ! ESMO - Eur. Oncology

Come join the Overby and Huang labs for this PhD Studentship on developing microfluidics to study cell migration in #sarcomas CRUK Convergence Science Centre Bioengineering The ICR

We are greatful to Sarcoma UK for funding this project.

Details for applying 👇

findaphd.com/phds/project/m…

📣📣📣 Dear colleagues & ESMO - Eur. Oncology members, please help us to understand more about current role & future potential of #DigitalHealth technology in #oncology 💻

📋Link to our #ESMOYOC survey:
esmo.eu.qualtrics.com/jfe/form/SV_4V…

Matteo Lambertini, MD PhD Andres Cervantes Evandro de Azambuja, MD, PhD francescalongo

📣 Interested in submitting an application for the 2024 ANZSA Sarcoma Research Grants? Apply now!

This year, we are offering two 12-month grants with support from our generous donors to fund new sarcoma research.

Visit our website for more information: sarcoma.org.au/2024sarcomares…

A nice contribution of ⁦McGill_Sarcoma⁩ group to the literature on myxoid liposarcoma. Definitely, in my experience, whole-body MRI made a difference. Happy to see our publication come through. link.springer.com/article/10.100…

New frontiers in exploiting stroma for therapy. FAP directed precision medicine. Phase I of AVA600 showing tolerability, plasmas/tumour PK and clinical proof of concept response in FAP high tumours. Abstract CT188 #AACR2024 The ICR The Royal Marsden NHS Foundation Trust ECMC Network

Very special morning getting to show Senators Askew & Kovacic around ProCan & CMRI

Great to discuss our #proteomic research & challenges faced in #sarcoma , rare&young people cancer care&research 💛

Eagerly await Equity in #RareCancers
senate #enquiry report coming 16/5/24